Histology and Cytology Market Report 2026

The histology and cytology market size has grown rapidly in recent years. It will grow from $19.21 billion in 2025 to $21.54 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increasing cancer diagnostic testing volumes, expansion of hospital laboratory infrastructure, rising adoption of microscopy-based diagnostics, growth in clinical research activities, availability of standardized staining reagents.

The histology and cytology market size is expected to see rapid growth in the next few years. It will grow to $32.42 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to increasing demand for early disease detection, rising integration of ai-driven diagnostics, expansion of personalized medicine approaches, growing investments in laboratory automation, increasing adoption of remote pathology solutions. Major trends in the forecast period include increasing adoption of digital pathology systems, rising use of automated tissue processing solutions, growing integration of AI-based image analysis, expansion of advanced cytology screening techniques, enhanced focus on high-throughput laboratory workflows.

The rising prevalence of cancer is expected to drive the growth of the histology and cytology market in the coming years. Cancer encompasses a broad group of diseases characterized by the uncontrolled growth and spread of abnormal cells, which can invade normal tissue and potentially metastasize to other parts of the body. Factors contributing to increasing cancer prevalence include an aging population, poor diet, lack of physical activity, excessive alcohol consumption, industrial pollutants, and inherited genetic mutations. Histology and cytology play a crucial role across the cancer care continuum, from initial diagnosis and treatment planning to monitoring therapeutic response, significantly influencing patient outcomes. For example, in July 2024, the Australian Institute of Health and Welfare reported that in 2023, approximately 165,000 Australians were newly diagnosed with cancer, averaging over 450 cases daily, with males accounting for about 55% of these cases. This growing prevalence is fueling demand in the histology and cytology market.

Key companies in the histology and cytology market are focusing on innovative solutions such as AI-assisted cervical cytology platforms to improve diagnostic accuracy, streamline workflows, and enhance patient outcomes. An AI-assisted cervical cytology platform utilizes artificial intelligence to analyze cervical cell samples, increasing detection precision, reducing errors, and expediting Pap smear screening. For instance, in February 2024, Hologic Inc., a US-based medical technology company, launched the Genius™ Digital Diagnostics System, the first FDA-cleared digital cytology system combining deep-learning AI with advanced volumetric imaging technology. It is designed to identify precancerous lesions and cervical cancer cells more accurately than conventional microscopy methods.

In May 2024, Veranex, a US-based contract research organization, acquired HORUS Scientific for an undisclosed amount. This acquisition enables Veranex to expand its laboratory capabilities, enhance tissue-based research services, strengthen client partnerships, and accelerate growth in precision medicine solutions. HORUS Scientific is a US-based provider specializing in pathology and histology services, including tissue analysis and diagnostics for preclinical and clinical research.

Major companies operating in the histology and cytology market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Agilent Technologies Inc., Hologic Inc., Leica Microsystems Nussloch GmbH, Sakura Finetechnical Company Ltd., Biogenex Laboratories Inc., StatLab Medical Products Inc., Biocare Medical LLC, A. Menarini Diagnostics S.r.l, Milestone Medical Inc., Diapath S.p.A., CellPath USA, Medite Medical GmbH, Histo-Line Laboratories s.r.l., Hacker Instruments & Industries Inc., Amos Scientific Pty. Ltd., TissueGnostics GmbH, Konfoong Bioinformation Tech Co. Ltd., Intelsint Srl.

North America was the largest region in the histology and cytology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the histology and cytology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the histology and cytology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the histology and cytology market by increasing costs of imported laboratory instruments, optical components, digital imaging systems, reagents, and consumables used in tissue and cell analysis. Diagnostic laboratories and research institutions in North America and Europe are most affected due to reliance on imported high-precision equipment, while Asia-Pacific faces cost pressure on instrument manufacturing and exports. These tariffs are raising operational costs and delaying equipment upgrades. However, they are also encouraging localized manufacturing of laboratory instruments, regional reagent production, and increased investment in domestic diagnostic infrastructure.

The histology and cytology market research report is one of a series of new reports that provides histology and cytology market statistics, including histology and cytology industry global market size, regional shares, competitors with a histology and cytology market share, detailed histology and cytology market segments, market trends and opportunities, and any further data you may need to thrive in the histology and cytology industry. This histology and cytology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Histology and cytology are complementary disciplines within biology and medicine that focus on the microscopic study of tissues and cells, respectively. Histology examines tissue samples under a microscope to identify abnormalities in tissue structure and cellular organization, supporting the diagnosis of conditions such as cancer, inflammatory diseases, and infections. Cytology focuses on individual cells, often collected from body fluids or fine-needle aspirations, to detect cellular changes associated with diseases like cancer, infections, and autoimmune disorders. Together, histology and cytology provide comprehensive insights into disease processes, enable early detection, guide treatment decisions, and monitor therapy effectiveness, ultimately improving patient outcomes.

The primary products in the histology and cytology market include instruments, analysis software systems, consumables, and reagents. Instruments and software systems consist of integrated hardware and software solutions for data acquisition, processing, and interpretation in scientific and clinical settings. Key test types include microscopy, flow cytometry, and molecular genetic methods, applied across drug discovery, clinical diagnostics, and academic research. These products are used by a range of end users, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations (CDMOs), diagnostic laboratories, and other stakeholders.

The histology and cytology market includes revenues earned by entities by entities by providing services such as screening tests, clinical diagnostics, academic research, and drug discovery and designing to detect and classify cancerous cells and related tissue processing equipment, staining reagents, histological slides, immunohistochemistry (IHC), liquid-based cytology systems, and cytology slide preparation equipment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.